Louis J. DeGennaro, Ph.D.
Chief Mission Officer
As chief mission officer, Louis J. DeGennaro Ph.D., is responsible for oversight of all LLS mission functions: public policy, patient access, educaton and advocacy services and research, with the goal of effectively deploying resources in pursuit of the LLS mission.
DeGennaro has more than 25 years of research, drug development and executive management experience in academic and private-sector settings. He received his Ph.D. in biochemistry from the University of California at San Francisco and did his postdoctoral research at Yale University School of Medicine. His previous academic appointments include research group leader at Max Planck Institute in Munich, Germany, and associate professor of neurology and cell biology at the University of Massachusetts Medical School.
DeGennaro's private-sector positions include senior director of molecular genetics at Wyeth Pharmaceuticals, Princeton, NJ, and executive vice president for research and development, SynX Pharma, Inc., Toronto, Canada.